Skip to content

Author

Peter A. Pinto

3 papers indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access Sep 2026

Impact of MRI Quality on the Accuracy of Targeted Prostate Biopsy: A Prospective PI-QUAL Analysis

Background and Objectives: Multiparametric MRI (mpMRI) has improved the detection of clinically significant prostate cancer (csPCa). However, the diagnostic utility of mpMRI is heavily dependent on image quality, which is often inconsistent across clinical settings. We investigated the association between mpMRI quality...

Donald C. Wunsch, O. Esengur, R. Makwana et al. · 0 citations
Aug 2026

Long‐Term Oncologic Outcomes of Neoadjuvant Tumor‐Directed Immunotherapy (PROSTVAC) Before Radical Prostatectomy for Localized Prostate Cancer: A Secondary Analysis of a Neoadjuvant Trial

Biochemical recurrence (BCR) following radical prostatectomy (RP) occurs in 20%–40% of patients with localized prostate cancer. Neoadjuvant PROSTVAC has been shown to enhance T‐cell infiltration into the tumor immune microenvironment, but whether these immunologic changes translate into improved long‐term oncologic out...

B. Millan, Alexander P. Kenigsberg, Charles Hesswani et al. · 0 citations
Open access Sep 2026

Defining a Safe Biopsy Deferral Strategy in Patients With Low-Risk or Equivocal MRI Findings Using Prostate-Specific Antigen-Based Metrics.

This prospective single-center study examined whether prostate-specific antigen (PSA)-based measures could identify a low-risk subgroup suitable for biopsy deferral in patients with Prostate Imaging-Reporting and Data System (PI-RADS) 1-3 lesions, and which clinical & imaging factors further refined risk stratification...

O. Esengur, S. Harmon, Emma J. Stevenson et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.